4
Changes in Ownership
agilon health, inc. Filed Acc 0001209191-23-028800
Chief Strategy & Dev. Officer sold 4,500 shares at $26.15 ($117,666)
- Chief Strategy & Dev. Officer acquired 4,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Desai Veeral Chief Strategy & Dev. Officer | 2023-05-09 | Option exercise 10b5-1 | +4,500 | $3.00 | $13,500 | 304,085 | D |
| Desai Veeral Chief Strategy & Dev. Officer | 2023-05-09 | Sale 10b5-1 | −4,500 | $26.15 | $117,666 | 299,585 | D |
| Derivatives | |||||||
| Desai Veeral Chief Strategy & Dev. Officer | 2023-05-09 | Option exercise · Options (Rights to Buy) 10b5-1 | −4,500 | 1,510,000 | D | ||
| Open-market sales · 4,500 sh · avg $26.15 · $117,666 | |||||||
Loading xslF345X04/doc4.xml…